Is Glenmark Pharmaceuticals Setting Up for a Medium-Term Recovery After a Double Bottom Pattern?
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is currently positioned inside a falling trend channel over the medium-term timeframe. This pattern reflects earlier selling pressure and rising caution among market participants.
However, the stock has formed a double-bottom structure — one of the most reliable reversal formations. A technical bullish signal has already been generated with upside potential toward ₹1,986.
Many traders monitor such reversal structures using confirmation-based execution models — similar to timing entries with a Nifty Intraday Call framework to avoid premature entries.
Technical Highlights
🔹 Double-bottom formation supports medium-term bullish reversal
🔹 Fresh breakout signal points to upside continuation
🔹 Current support: ₹1,898
🔹 Breakdown risk only below ₹1,820
Volume Behaviour
Volume characteristics suggest improving confidence — accumulation phases appear stronger than distribution phases, indicating growing optimism despite the falling channel structure.
A sustained hold above support followed by a confirmation breakout above ₹1,986 may validate the reversal structure and strengthen medium-term upside potential.
Investor Takeaway
While near-term volatility cannot be ruled out, the structure now supports a constructive technical view for long-term traders. Breakout confirmation will be key.
More expert-guided setups available at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
